Valuation NFL Biosciences Börse Stuttgart

Stocks

Market Closed - Börse Stuttgart 15:55:27 2026-08-28 EDT			5-day change	1st Jan Change
0.8320 ^EUR	-2.92%		+3.74%	-21.95%

07-28	NFL Biosciences Submits Application For Authorization Of The Phase 2 Tonic Clinical Trial Evaluating NFL-102 In Smoking Cessation	CI
07-07	Nfl Biosciences Presents Three Scientific Communications on Nfl-101 and Nfl-102 At 2026 Srnt-Europe Conference	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025
Market Cap ¹	12.56	10.29	11.67	19.12	14.93
Change	-	-18.12%	13.49%	63.78%	-21.92%
Enterprise Value (EV) ¹	9.443	9.155	9.206	17.05	13.31
Change	-	-3.05%	0.56%	85.17%	-21.93%
P/E	-12.8x	-4.21x	-3.14x	-9.56x	-4.62x
PBR	3.82x	12.2x	33.6x	19.8x	48.8x
PEG	-	-0x	1.88x	0.2x	-0.2x
Capitalization / Revenue	322,130x	467,546x	58.4x	415,647x	79,404x
EV / Revenue	242,134x	416,129x	46x	370,592x	70,790x
EV / EBITDA	-11x	-3.02x	-2.21x	-6.26x	-3.51x
EV / EBIT	-10.5x	-2.97x	-2.18x	-6.11x	-3.44x
EV / FCF	-	-	-	-	-
FCF Yield	-	-	-	-	-
Dividend per Share ²	-	-	-	-	-
Rate of return	-	-	-	-	-
EPS ²	-0.1869	-0.4668	-0.459	-0.206	-0.255
Distribution rate	-	-	-	-	-
Net sales ¹	0.000039	0.000022	0.2	0.000046	0.000188
EBITDA ¹	-0.8584	-3.031	-4.174	-2.723	-3.786
EBIT ¹	-0.9019	-3.083	-4.23	-2.79	-3.873
Net income ¹	-0.9782	-2.443	-3.745	-2.081	-3.318
Net Debt ¹	-3.12	-1.131	-2.467	-2.073	-1.619
Reference price ²	2.4000	1.9650	1.4400	1.9700	1.1780
Nbr of stocks (in thousands)	5,235	5,235	8,107	9,705	12,672
Announcement Date	4/29/22	4/28/23	4/14/25	4/14/25	4/27/26

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
WUXI APPTEC CO., LTD.	20.59x	7.25x	14.66x	1.42%	69.54B
ARGENX SE	36.89x	9.62x	29.41x	0.04%	64.97B
BIONTECH SE	-15.61x	5.94x	-7.46x	-.--%	25.64B
INSMED INCORPORATED	-74.93x	13.98x	-67.43x	-.--%	25.89B
WUXI BIOLOGICS (CAYMAN) INC.	30.69x	6.58x	17.2x	-.--%	26.51B
PHARMAESSENTIA CORPORATION	58.27x	21.67x	43.95x	0.26%	20.22B
GENMAB A/S	27.27x	5.11x	16.98x	-.--%	19.98B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1415.29x	39.34x	858.54x	-.--%	15.69B
EXELIXIS, INC.	16.84x	5x	11.66x	-.--%	13.49B
Average	168.37x	12.72x	101.95x	0.19%	31.33B
Weighted average by Cap.	93.83x	10.79x	57.82x	0.38%